Refer your Patient for Psilocybin-Assisted Psychotherapy

TheraPsil is helping patients to access medical psilocybin

What is Psilocybin-Assisted Psychotherapy ?

Psilocybin-assisted psychotherapy refers to the professionally guided use of psilocybin (‘magic mushrooms’) in combination with psychotherapy.

TheraPsil’s clinical protocol encompasses careful medical oversight from trained multidisciplinary treatment teams with comprehensive psychotherapy before and after each psilocybin session. This therapy has been shown in numerous clinical studies to reduce existential distress, relieve depression and reduce or eliminate the fear of death.

Want to learn more about psilocybin-assisted psychotherapy?

Prescribers are encouraged to enroll in TheraPsil's 'Psilocybin Therapy Training Program'.
Learn more and sign up by visiting our training page.

Prescriber Sign Up Form

Select all that apply:

Do you have questions?

Contact us at .

Disclaimer: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE

The information, including but not limited to, text, graphics, images, educational content, supporting documents and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for professional medical education. We do not authorize or advise any practice, scope, diagnosis or treatment approach.  All practitioners viewing this content are solely responsible for their own professional practice. TheraPsil, TheraPsil consultant and  TheraPsil employees are in no way responsible for any health care professional’s practice.  

Please Note: WE ARE COMMITTED TO COMPLETELY LEGAL BEHAVIOUR in our advocacy of psilocybin for medical purposes. Recommending the therapeutic use of a psychedelic substance, providing psychedelic psychotherapy, or referring an individual to a therapist for psychedelic therapy is currently illegal, as these actions can open us to the criminal charge of aiding and abetting the possession of a controlled substance.

Want to sign up for our Newsletter to stay in the loop?

Subscribe